What is the management approach for hypocalcaemia (low calcium levels) in a general adult patient?

Management of Hypocalcaemia

Immediate Assessment and Diagnosis

Measure pH-corrected ionized calcium (the most accurate test) and immediately check magnesium levels in all hypocalcemic patients, as hypomagnesemia must be corrected first before calcium replacement will be effective. 1, 2

• Check parathyroid hormone (PTH), magnesium, thyroid-stimulating hormone, and creatinine concentrations to determine the underlying cause 1
• Obtain an ECG to assess for QT prolongation and cardiac arrhythmias 1
• Hypomagnesemia is present in 28% of hypocalcemic patients and causes hypocalcemia through two mechanisms: impaired PTH secretion and end-organ resistance to PTH 3, 2

---

Acute Symptomatic Hypocalcemia Management

For severe symptomatic hypocalcemia (tetany, seizures, laryngospasm, cardiac arrhythmias), administer calcium chloride 10% solution 10 mL (270 mg elemental calcium) intravenously over 2-5 minutes with continuous ECG monitoring. 3, 4

Calcium Chloride vs Calcium Gluconate

• Calcium chloride is strongly preferred over calcium gluconate because 10 mL of 10% calcium chloride contains 270 mg elemental calcium versus only 90 mg in calcium gluconate 3
• Administer via a secure central or deep vein, not to exceed 1 mL/min 4
• If calcium chloride is unavailable, use calcium gluconate 10% solution 15-30 mL IV over 2-5 minutes 3

Critical Concurrent Intervention

• If hypomagnesemia is present, administer magnesium sulfate 1-2 g IV bolus immediately BEFORE calcium replacement 3, 2
• Calcium supplementation alone will fail without correcting magnesium first 2
• Calcium normalization requires approximately 4 days after initiating magnesium therapy, even when PTH normalizes within 24 hours 2

Monitoring During Acute Treatment

• Maintain continuous ECG monitoring during rapid calcium administration due to risk of arrhythmias 3, 5
• Measure ionized calcium every 4-6 hours during intermittent infusions and every 1-4 hours during continuous infusion 5
• Halt injection if patient complains of discomfort; resume when symptoms disappear 4

Special Considerations

• Never administer calcium through the same line as sodium bicarbonate or phosphate-containing fluids as precipitation will occur 3, 5
• Use extreme caution when phosphate levels are high due to risk of calcium-phosphate precipitation in tissues 3
• During massive transfusion, citrate in blood products chelates calcium; monitor ionized calcium closely and provide continuous replacement 3

---

Chronic Hypocalcemia Management

Daily calcium carbonate (1-2 g elemental calcium in divided doses, not exceeding 2,000 mg/day total) plus vitamin D supplementation is the foundation of chronic hypocalcemia treatment. 1, 3

Oral Calcium Supplementation

• Calcium carbonate is the preferred first-line agent due to highest elemental calcium content, low cost, and wide availability 3
• Limit individual doses to 500 mg elemental calcium to optimize absorption 3
• Divide doses throughout the day to improve absorption and minimize gastrointestinal side effects 3
• Use calcium citrate instead in patients with achlorhydria or those taking acid-suppressing medications 3

Vitamin D Supplementation

• Daily vitamin D supplementation is recommended for all adults with chronic hypocalcemia 1, 3
• Correct vitamin D deficiency (25-OH vitamin D <30 ng/mL) with native vitamin D (cholecalciferol or ergocalciferol) 1
• Reserve hormonally active vitamin D metabolites (calcitriol) for severe or refractory cases, typically requiring endocrinologist consultation 1, 3
• For hypoparathyroidism, initial calcitriol dose is 20-30 ng/kg body weight daily or alfacalcidol 30-50 ng/kg body weight daily; alternatively start with 0.5 μg daily in patients >12 months old 1

Target Calcium Levels

• Maintain serum calcium in the low-normal range (8.4-9.5 mg/dL) to minimize hypercalciuria and prevent renal complications 3, 6
• In CKD stage 5 patients, maintain calcium toward the lower end of normal range 3

Monitoring Requirements

• Measure serum calcium and phosphorus at least every 3 months during chronic supplementation 1, 3
• Monitor for hypercalciuria to prevent nephrocalcinosis, especially when using active vitamin D metabolites 1
• Discontinue vitamin D therapy if serum calcium exceeds 10.2 mg/dL to avoid hypercalcemia 1
• Maintain calcium-phosphorus product <55 mg²/dL² to prevent metastatic calcification 1, 3

---

High-Risk Situations Requiring Enhanced Surveillance

Targeted calcium monitoring is critical during biological stress periods including surgery, childbirth, pregnancy, acute illness, fractures, and injuries. 1, 3

• Measure ionized calcium every 4-6 hours for the first 48-72 hours after thyroid or parathyroid surgery, then twice daily until stable 3
• Monitor perioperatively, perinatally, and during acute illness in all patients with history of hypocalcemia 1
• Patients with 22q11.2 deletion syndrome have 80% lifetime prevalence of hypocalcemia and require heightened surveillance during all stress periods 7, 1

---

Critical Safety Considerations and Pitfalls

Overcorrection Risks

• Overcorrection can result in iatrogenic hypercalcemia, renal calculi, and renal failure 1, 3
• This can occur inadvertently with dehydration or treatment compliance changes 7
• Careful monitoring and dose adjustment are essential to prevent overcorrection 3

Extravasation and Tissue Damage

• Calcinosis cutis can occur with or without extravasation of calcium injection 5
• Tissue necrosis, ulceration, and secondary infection are the most serious complications 5
• If extravasation occurs, immediately discontinue IV administration at that site 5

Drug Interactions

• If patient is on cardiac glycosides, administer calcium slowly in small amounts with close ECG monitoring due to synergistic arrhythmia risk 5
• Calcium channel blockers may have reduced response when calcium is administered 5
• Never administer ceftriaxone concurrently with IV calcium in neonates due to fatal precipitate formation 5

Lifestyle Modifications

• Advise patients to avoid alcohol and carbonated beverages (especially colas) as they worsen hypocalcemia 7, 1

---

Special Population Considerations

CKD and Dialysis Patients

• Use an individualized approach rather than routine correction in all CKD patients 1
• Do not use calcium-based phosphate binders when corrected serum calcium >10.2 mg/dL or PTH <150 pg/mL on 2 consecutive measurements 3
• Elemental calcium from calcium-based phosphate binders should not exceed 1,500 mg/day 3
• For intensive hemodialysis, use dialysate calcium ≥1.50 mmol/L (3.0 mEq/L) to maintain neutral or positive calcium balance 3

Post-Parathyroidectomy Hungry Bone Syndrome

• Initiate calcium gluconate infusion at 1-2 mg elemental calcium per kg body weight per hour if ionized calcium falls below 0.9 mmol/L 3
• When oral intake is possible, provide calcium carbonate 1-2 g three times daily plus calcitriol up to 2 mcg/day 3

Patients on Bisphosphonates or Denosumab

• Provide oral calcium and vitamin D3 supplementation to prevent severe hypocalcemia 1
• Identify at-risk patients before starting bone resorption inhibitors and monitor closely during first few months 8